Table 2: Showing variability of sensitivity depending on site of sample collection in 205 COVID-19 Wuhan patients [44].
|
Sample's source |
Sensitivity |
|
Bronchoalveolar lavage fluid specimens |
93% (14/15) |
|
Sputum |
72% (75/104) |
|
Nasal swabs |
63% (5/8) |
|
Fibro bronchoscope brush biopsy |
46% (6/13) |
|
Pharyngeal swabs |
32% (126/398) |
|
Feces |
29% (44/153) |
|
Blood |
1% (3/307) |